(138 days)
No
The document describes calibrators for in-vitro diagnostic assays, which are chemical reagents used for calibration. There is no mention of any computational or algorithmic components, let alone AI/ML.
No
This device is described as a calibrator for assays, used to test human serum and plasma. It does not directly treat or diagnose a disease, nor does it affect the structure or function of the body. Its purpose is to ensure the accurate measurement of certain substances.
No
This device is described as a calibrator for assays, used to ensure correct assay calibration for measuring specific drugs in human serum and plasma. It aids in the accurate functioning of diagnostic assays but is not a diagnostic device itself.
No
The device description clearly states the device is manufactured using physical components (bovine serum albumin, digoxin, N-acetylprocainamide, procainamide, stabilizers, and preservatives) and is a calibrator for laboratory assays, not a software product.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states that the calibrators are used to calibrate assays for digoxin, N-acetylprocainamide, and procainamide in human serum and plasma. This indicates that the device is intended for use in examining specimens derived from the human body to provide information for diagnostic purposes.
- Device Description: The description mentions that the calibrators are used to ensure correct assay calibration for the CEDIA assays. These assays are used to measure the levels of specific substances in human samples, which is a core function of IVDs.
- Predicate Devices: The predicate devices listed (CEDIA Digoxin, TDx Procainamide, TDx N-acetylprocainamide Assays) are all IVD assays used for therapeutic drug monitoring (TDM). Calibrators are essential components of such IVD systems.
Therefore, based on the provided information, the CEDIA Cardiac TDM Multi-Cals are clearly intended for use in an in vitro diagnostic context.
N/A
Intended Use / Indications for Use
The CEDIA Cardiac TDM Multi-Cals are used to calibrate the CEDIA assays for digoxin, N-acetylprocainamide, and procainamide, in human serum and plasma.
Product codes
Not Found
Device Description
The CEDIA Cardiac TDM Calibrators are manufactured using bovine serum albumin, digoxin, N-acetylprocainamide, procainamide, stabilizers, and preservatives. The drugs are appropriately spiked into the calibrator matrix to the correct calibrator concentration levels. The calibrators are in process checked and quality controlled against in-house reference calibrators (prepared using a similar procedure) which have been value assigned by comparison to the predicate device to ensure correct assay calibration.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Method Comparison: equivalent correlation between predicate device kit calibrators and CEDIA Cardiac TDM Multi-Cals.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1150 Calibrator.
(a)
Identification. A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
ﺳﮯ
K962269 | OCT 29 1996 | ||
---|---|---|---|
510(k) Summary | |||
Introduction | According to the requirements of 21 CFR 807.92, the following information | ||
provides sufficient detail to understand the basis for a determination of | |||
substantial equivalence. | |||
1. | |||
Submitter | |||
name, | |||
address, | |||
contact | Boehringer Mannheim Corporation | ||
2400 Bisso Lane | |||
Concord, CA 94524-4117 | |||
(510) 674-0690 extension 8415 | |||
Contact Person: Mary Koning | |||
Date Prepared: October 25, 1996 | |||
2. | |||
Device name | Proprietary name: CEDIA Cardiac TDM Multi-Cals | ||
Common name: Therapeutic drug monitoring calibrators for use in the | |||
calibration of the CEDIA assays for digoxin, N-acetylprocainamide, and | |||
procainamide. | |||
Classification name: Calibrators, drug mixture | |||
3. | |||
Predicate | |||
device | The Boehringer Mannheim CEDIA Cardiac TDM Multi-Cals are | ||
substantially equivalent to the kit calibrators included in CEDIA Digoxin | |||
(K910642), TDx Procainamide (K834464), and TDx N-acetylprocainamide | |||
(K830206) Assays. | |||
4. | |||
Device | |||
Description | The CEDIA Cardiac TDM Calibrators are manufactured using bovine serum | ||
albumin, digoxin, N-acetylprocainamide, procainamide, stabilizers, and | |||
preservatives. The drugs are appropriately spiked into the calibrator matrix | |||
to the correct calibrator concentration levels. The calibrators are in process | |||
checked and quality controlled against in-house reference calibrators (prepared | |||
using a similar procedure) which have been value assigned by comparison to | |||
the predicate device to ensure correct assay calibration. | |||
5. | |||
Intended use | The CEDIA Cardiac TDM Multi-Cals are used to calibrate the CEDIA | ||
assays for digoxin, N-acetylprocainamide, and procainamide, in human serum | |||
and plasma. | |||
6. | |||
Comparison | |||
to predicate | |||
device | The Boehringer Mannheim CEDIA Cardiac TDM Multi-Cals are | ||
substantially equivalent to the kit calibrators included in CEDIA Digoxin | |||
(K910642), TDx Procainamide (K834464), and TDx N-acetylprocainamide | |||
(K830206) Assays. | |||
The following table compares the CEDIA Cardiac TDM Multi-Cals with the | |||
predicate devices, CEDIA Digoxin, TDx Procainamide, and TDx N- | |||
acetylprocainamide assay's kit calibrators. Specific data on the performance | |||
of the test have been incorporated into the draft labeling in attachment 5. | |||
Labeling for the predicate device in provided in attachment 6. | |||
Similarities: |
Continued on next page
1
510(k) Summary, Continued
· Similar concentrations of digoxin, N-acetylprocainamide, and procainamide.
Differences:
Feature | Cardiac TDM Multi-Cals | Kit Calibrators |
---|---|---|
Configuration | sold separately from reagents | sold with reagents in kit |
Number of calibrators in | ||
set (N-acetylprocainamide, | ||
Procainamide) | 2 | 6 |
Matrix | Bovine Serum Albumin | Human Serum |
Continued on next page
2
ટેસ
510(k) Summary, Continued
Performance Characteristics: 6. Comparison to predicate device, (cont.)
· Method Comparison: equivalent correlation between predicate device kit calibrators and CEDIA Cardiac TDM Multi-Cals.